用机器学习为患有水性腹的儿童提供个性化阿兹罗米辛治疗规则
Sara S Kim1, Allison Codi2, James A Platts-Mills3
1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
medRxiv : the preprint server for health sciences
|November 22, 2024
概括
机器学习识别了个性化策略,以向阿齐思罗米辛的水性腹的儿童. 这种方法有效地减少了目标群体的腹和严重后果,如重新住院和死亡.
科学领域:
- 儿童传染病 儿童传染病
- 临床试验方法论 临床试验方法论
- 机器学习在医疗保健中的应用
背景情况:
- 水性腹是全球儿童发病率和死亡率的重要原因.
- 阿齐思罗米已在治疗某些类型的腹方面表现出有效性,但需要最佳的向.
- 个性化医疗方法可以提高抗生素的有效性并减少耐药性.
研究的目的:
- 通过机器学习开发和验证在患有水性腹的儿童中使用阿齐思罗米的个性化治疗规则.
- 为了确定儿童和临床特征,预测阿齐思罗米辛治疗的益处.
- 评估向性阿齐思罗米辛治疗对腹持续时间和严重结果的影响.
主要方法:
- 利用了阿齐思罗米治疗水性腹的随机试验的数据.
- 采用集体机器学习程序,根据诊断,儿童和临床特征制定个性化治疗规则.
- 估计每一个衍生规则的治疗比例和平均效益.
主要成果:
- 个性化治疗规则建议阿齐思罗米辛在6,692名儿童中约占三分之一.
- 与安慰剂相比,向性阿齐思罗米辛减少了腹风险10.1%,再住院/死亡风险2.4%.
- 主体特征比病原体诊断更能预测严重结局的好处.
结论:
- 机器学习可以识别那些最有可能受益于在水性腹中使用阿齐思罗米辛的儿童.
- 基于宿主特征的针对性抗生素治疗可能在没有病原体诊断的情况下是可行的.
- 个性化阿齐思罗米辛策略有望改善儿科腹管理.
更多相关视频
10:50Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection
Published on: September 27, 2016
9.8K
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
13.2K
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
207
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
207
Drugs for Treatment of Diarrhea-Predominant IBS
317
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
317
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
328
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
328
